Effect of risk group on survival in non-Wilms' renal tumors in children
Öz
Purpose: The aim of this study was to evaluate tne effect of the risk group on the clinical features of the disease, treatment strategies and especially survival in children with Non-Wilms’ renal tumors (NWRTs).
Materials and Methods: Patients diagnosed with NWRTs followed up and treated between January 2012 and January 2022 were included in the study (n=29; 16 boys and 13 girls). They were categorized into high- and low-risk groups based on their histological type. Patient records were reviewed retrospectively. Clinical characteristics, treatments, and outcomes of these patients were analyzed.
Results: The high-risk group comprised clear cell sarcoma (CCSK) (n=8, 27.6%), malignant rhabdoid tumor (MRT) (n=3, 10.3%), renal cell carcinoma (n=2, 6.9%), non-Hodgkin lymphoma (n=1, 3.4%), and primitive neuroectodermal tumor (PNET) (n=1, 4%). The low-risk group comprised congenital mesoblastic nephroma (CMN) (n=9, 31%), angiomyolipoma (n=4, 3.8%), and hemangioma (n=1, 3.4%). Five patients died due to disease progression (mortality rate, 17%), all of whom belonged to the high-risk group (three patients with MRT, one with CCSK, one with PNET). The 5-year survival rate was 72% for the high risk group and 100% for the low risk group.
Conclusion: Although low-risk tumors are associated with excellent outcomes, the outcomes vary in high-risk tumors. Physicians should be wary of high mortality rates in children with MRT, CCSK, and PNET, and should design multidisciplinary treatments for NWRTs.
Anahtar Kelimeler
Kaynakça
- Referans1 Fernandez CV, Geller JI, Ehrlich PF, van den Heuvel-Eibrink, Graf N, Mullen E et al. Renal tumors. In Pizzo and Poplack’s Pediatric Oncology, 8th ed. (Eds Blaney SM, Helman LJ, Adamson PC). Philadelphia: Wolters Kluwer, 2021;673-92.
- Referrans2 Ahmed HU, Arya M, Levitt G, Duffy PG, Mushtaq I, Sebire NJ. Part I: Primary malignant non-Wilms’ renal tumours in children. Lancet Oncol 2007;8:730-7.
- Referans3 Broecker B. Non-Wilms renal tumors in children. Urol Clin North Am 2000; 27: 463–9.
- Referans4 Qureshi SS, Bhagat M, Verma K, Yadav S, Prasad M, Vora T et al. Incidence, treatment, and outcomes of primary and recurrent Non-Wilms renal tumors in children: Report of 109 patients treated at a single institution. J Pediatr Urol 2020;16(4):475.e1-475.e9.
- Referans5 van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: a collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer 2008;50:1130–4.
- Referans6 Argani P, Perlman EJ, Breslow NE, Browning NG, Green DM, D'Angio GJ et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumour Study Pathology Center. Am J Surg Path 2000; 24: 4–18.
- Referans7 Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 2004; 101:1575–83.
- Referans8 Qureshi SS, Kembhavi S, Vora T, Ramadwar M, Laskar S, Talole S et al. Prognostic factors in primary nonmetastatic Ewing sarcoma of the rib in children and young adults. J Pediatr Surg 2013; 48: 764-70.
- Referans9 Zhu Y, Fu W, Huang Y, Sun N, Peng Y. Imaging features and differences among the three primary malignant non-Wilms tumors in children. BMC Med Imaging 2021;21(1):181.
- Referans10 Bozlu G, Çıtak EÇ. Evaluation of renal tumors in children. Turk J Urol 2018; 44(3): 268-73.
